Polyunsaturated very-long-chain C28-C36 fatty acids and retinal physiology

British Journal of Ophthalmology

Volumn 94, Issue 9, 2010, Pages 1127-1132

  McMahon, Anne ^a   Kedzierski, Wojciech ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; ELOVL4 PROTEIN, HUMAN; EYE PROTEIN; MEMBRANE PROTEIN; UNSATURATED FATTY ACID;

BIOSYNTHESIS; ELECTRORETINOGRAPHY; ELOVL4 GENE; FATTY ACID SYNTHESIS; GENE; GENE DELETION; GENETIC MODEL; HUMAN; LIPID MEMBRANE; NONHUMAN; PHOTORECEPTOR; PHOTOTRANSDUCTION; PRIORITY JOURNAL; RETINA; REVIEW; STARGARDT DISEASE; ANIMAL; BOVINAE; CHEMISTRY; DISEASE MODEL; FORECASTING; GENETICS; MACULAR DEGENERATION; MOUSE; PHYSIOLOGY;

ANIMALS; CATTLE; DISEASE MODELS, ANIMAL; EYE PROTEINS; FATTY ACIDS, UNSATURATED; FORECASTING; HUMANS; MACULAR DEGENERATION; MEMBRANE PROTEINS; MICE; RETINA;

EID: 77956395236     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.149286     Document Type: Review

References (83)

1. McMahon A, Jackson SN, Woods AS, et al. A Stargardt disease-3 mutation in the mouse Elovl4 gene causes retinal deficiency of C32-C36 acyl phosphatidylcholines. FEBS Lett 2007;581:5459-63.
2. McMahon A, Butovich IA, Mata NL, et al. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4. Mol Vis 2007;13:258-72. (Pubitemid 46323316)
3. Stone EM, Nichols BE, Kimura AE, et al. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch Ophthalmol 1994;112:765-72.
4. Edwards AO, Miedziak A, Vrabec T, et al. Autosomal dominant Stargardt-like macular dystrophy: I. Clinical characterization, longitudinal follow-up, and evidence for a common ancestry in families linked to chromosome 6q14. Am J Ophthalmol 1999;127:426-35. (Pubitemid 32913486)
5. Lagali PS, MacDonald IM, Griesinger IB, et al. Autosomal dominant Stargardt-like macular dystrophy segregating in a large Canadian family. Can J Ophthalmol 2000;35:315-24.
6. Donoso LA, Edwards AO, Frost A, et al. Autosomal dominant Stargardt-like macular dystrophy. Surv Ophthalmol 2001;46:149-63. (Pubitemid 32913486)
7. Maugeri A, Meire F, Hoyng CB, et al. A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy. Invest Ophthalmol Vis Sci 2004;45:4263-7.
8. Hubbard AF, Askew EW, Singh N, et al. Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation. Arch Ophthalmol 2006;124:257-63. (Pubitemid 43247077)
9. MacDonald IM, Hebert M, Yau RJ, et al. Effect of docosahexaenoic acid supplementation on retinal function in a patient with autosomal dominant Stargardtlike retinal dystrophy. Br J Ophthalmol 2004;88:305-6.
10. Zhang K, Kniazeva M, Han M, et al. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy. Nat Genet 2001;27:89-93.
11. Edwards AO, Donoso LA, Ritter R 3rd. A novel gene for autosomal dominant Stargardt-like macular dystrophy with homology to the SUR4 protein family. Invest Ophthalmol Vis Sci 2001;42:2652-63.
12. Bernstein PS, Tammur J, Singh N, et al. Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest Ophthalmol Vis Sci 2001;42:3331-6. (Pubitemid 33740698)
13. Anderson RE. Lipids of ocular tissues. IV. A comparison of the phospholipids from the retina of six mammalian species. Exp Eye Res 1970;10:339-44.
14. Rotstein NP, Aveldano MI, Politi LE. Essentiality of docosahexaenoic acid in retina photoreceptor cell development. Lipids 1999;34 (Suppl):S115.
15. Uauy R, Hoffman DR, Peirano P, et al. Essential fatty acids in visual and brain development. Lipids 2001;36:885-95. (Pubitemid 33065189)
16. Fleith M, Clandinin MT. Dietary PUFA for preterm and term infants: review of clinical studies. Crit Rev Food Sci Nutr 2005;45:205-29. (Pubitemid 41657357)
17. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005;24:87-138.
18. Cheatham CL, Colombo J, Carlson SE. N-3 fatty acids and cognitive and visual acuity development: methodologic and conceptual considerations. Am J Clin Nutr 2006;83:1458S-66S.
19. Johnson EJ, Schaefer EJ. Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration. Am J Clin Nutr 2006;83:1494S-8S.
20. Hoffman DR, DeMar JC, Heird WC, et al. Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa. J Lipid Res 2001;42:1395-401.
21. Maude MB, Anderson EO, Anderson RE. Polyunsaturated fatty acids are lower in blood lipids of Usher's type I but not Usher's type II. Invest Ophthalmol Vis Sci 1998;39:2164-6.
22. Aveldano MI. A novel group of very long chain polyenoic fatty acids in dipolyunsaturated phosphatidylcholines from vertebrate retina. J Biol Chem 1987;262:1172-9.
23. Aveldano MI, Sprecher H. Very long chain (C24 to C36) polyenoic fatty acids of the n-3 and n-6 series in dipolyunsaturated phosphatidylcholines from bovine retina. J Biol Chem 1987;262:1180-6. (Pubitemid 17028432)
24. Suh M, Wierzbicki AA, Clandinin MT. Dietary fat alters membrane composition in rod outer segments in normal and diabetic rats: impact on content of very-long-chain (C ≥ 24) polyenoic fatty acids. Biochim Biophys Acta 1994;1214:54-62. (Pubitemid 24269122)
25. Suh M, Wierzbicki AA, Clandini MT. Dietary n-3 FA modulate long and very long chain FA content, rhodopsin content, and rhodopsin phosphorylation in rat rod outer segment after light exposure. Lipids 2002;37:253-60.
26. Xi ZP, Wang JY. Effect of dietary n-3 fatty acids on the composition of long- and very-long-chain polyenoic fatty acid in rat retina. J Nutr Sci Vitaminol (Tokyo) 2003;49:210-13.
27. Aveldano MI. Phospholipid species containing long and very long polyenoic fatty acids remain with rhodopsin after hexane extraction of photoreceptor membranes. Biochemistry 1988;27:1229-39.
28. Kris-Etherton PM, Taylor DS, Yu-Poth S, et al. Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr 2000;71:179S-88S.
29. Rotstein NP, Aveldano MI. Synthesis of very long chain (up to 36 carbon) tetra, penta and hexaenoic fatty acids in retina. Biochem J 1988;249:191-200.
30. Suh M, Clandinin MT. 20:5n-3 but not 22:6n-3 is a preferred substrate for synthesis of n-3 very-long- chain fatty acids (C24-C36) in retina. Curr Eye Res 2005;30:959-68.
31. Rezanka T, Nedbalova L, Sigler K. Odd-numbered very-long-chain polyunsaturated fatty acids from the dinoflagellate Amphidinium carterae identified by atmospheric pressure chemical ionization liquid chromatography-mass spectrometry. Phytochemistry 2008;69:2849-55.
32. Agbaga MP, Brush RS, Mandal MN, et al. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids. Proc Natl Acad Sci U S A 2008;105:12843-8.
33. Sioen I, Matthys C, De Backer G, et al. Importance of seafood as nutrient source in the diet of Belgian adolescents. J Hum Nutr Diet 2007;20:580-9.
34. Brenna JT, Salem N Jr, Sinclair AJ, et al. α -Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids 2009;80:85-91.
35. Gerster H. Can adults adequately convert alpha-linolenic acid (18:3n-3) to eicosapentaenoic acid (20:5n-3) and docosahexaenoic acid (22:6n-3)? Int J Vitam Nutr Res 1998;68:159-73.
36. Pawlosky RJ, Hibbeln JR, Novotny JA, et al. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 2001;42:1257-65.
37. Burdge GC. Metabolism of α -linolenic acid in humans. Prostaglandins Leukot Essent Fatty Acids 2006;75:161-8.
38. Plourde M, Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 2007;32:619-34.
39. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr 2006;83:1467S-76S.
40. Balk E, Chung M, Lichtenstein A, et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. In: Evidence report/technology assessment. Number 93. Rockville, MD: Agency for Healthcare Research and Quality, 2004, 8-9. http://www.ahrq.gov/clinic/tp/ o3cardrisktp.htm.
41. Institute of Medicine of the National Academies. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC: The National Academies Press, 2005, 471. http://books.nap.edu/openbook.php?record-id=10490&page=R1.
42. Wakil SJ, Stoops JK, Joshi VC. Fatty acid synthesis and its regulation. Annu Rev Biochem 1983;52:537-79.
43. Jakobsson A, Westerberg R, Jacobsson A. Fatty acid elongases in mammals: their regulation and roles in metabolism. Prog Lipid Res 2006;45:237-49.
44. Leonard AE, Pereira SL, Sprecher H, et al. Elongation of long-chain fatty acids. Prog Lipid Res 2004;43:36-54.
45. Cameron DJ, Tong Z, Yang Z, et al. Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int J Biol Sci 2007;3:111-19.
46. Li W, Sandhoff R, Kono M, et al. Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int J Biol Sci 2007;3:120-8. (Pubitemid 46232773)
47. Vasireddy V, Uchida Y, Salem N Jr, et al. Loss of functional ELOVL4 depletes very long-chain fatty acids (≥C28) and the unique ω-O-acylceramides in skin leading to neonatal death. Hum Mol Genet 2007;16:471-82. (Pubitemid 46522611)
48. Nugteren DH. The enzymic chain elongation of fatty acids by rat-liver microsomes. Biochim Biophys Acta 1965;106:280-90.
49. Wang Y, Botolin D, Christian B, et al. Tissue-specific, nutritional, and developmental regulation of rat fatty acid elongases. J Lipid Res 2005;46:706-15. (Pubitemid 43073280)
50. Moon YA, Horton JD. Identification of two mammalian reductases involved in the two-carbon fatty acyl elongation cascade. J Biol Chem 2003;278:7335-43.
51. Kihara A, Sakuraba H, Ikeda M, et al. Membrane topology and essential amino acid residues of Phs1, a 3-hydroxyacyl-CoA dehydratase involved in very long-chain fatty acid elongation. J Biol Chem 2008;283:11199-209.
52. Rotstein NP, Pennacchiotti GL, Sprecher H, et al. Active synthesis of C24:5, n-3 fatty acid in retina. Biochem J 1996;316(Pt 3):859-64.
53. Furland NE, Maldonado EN, Aveldano MI. Very long chain PUFA in murine testicular triglycerides and cholesterol esters. Lipids 2003;38:73-80.
54. Rabionet M, van der Spoel AC, Chuang CC, et al. Male germ cells require polyenoic sphingolipids with complex glycosylation for completion of meiosis: a link to ceramide synthase-3. J Biol Chem 2008;283:13357-69.
55. Karan G, Lillo C, Yang Z, et al. Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci U S A 2005;102:4164-9. (Pubitemid 40388573)
56. Vasireddy V, Jablonski MM, Mandal MN, et al. Elovl4 5-bp-deletion knock-in mice develop progressive photoreceptor degeneration. Invest Ophthalmol Vis Sci 2006;47:4558-68. (Pubitemid 46579386)
57. Raz-Prag D, Ayyagari R, Fariss RN, et al. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease. Invest Ophthalmol Vis Sci 2006;47:3603-11.
58. Li W, Chen Y, Cameron DJ, et al. Elovl4 haploinsufficiency does not induce early onset retinal degeneration in mice. Vision Res 2007;47:714-22.
59. Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A 2000;97:7154-9.
60. Eldred GE, Lasky MR. Retinal age pigments generated by self-assembling lysosomotropic detergents. Nature 1993;361:724-6.
61. Holz FG, Schutt F, Kopitz J, et al. Inhibition of lysosomal degradative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci 1999;40:737-43. (Pubitemid 29109453)
62. Sparrow JR, Parish CA, Hashimoto M, et al. A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest Ophthalmol Vis Sci 1999;40:2988-95. (Pubitemid 29521615)
63. Finnemann SC, Leung LW, Rodriguez-Boulan E. The lipofuscin component A2E selectively inhibits phagolysosomal degradation of photoreceptor phospholipid by the retinal pigment epithelium. Proc Natl Acad Sci U S A 2002;99:3842-7. (Pubitemid 34252193)
64. Bressler NM. Age related macular degeneration. New hope for a common problem comes from photodynamic therapy. BMJ 2000;321:1425-7.
65. Edwards AO, Malek G. Molecular genetics of AMD and current animal models. Angiogenesis 2007;10:119-32. (Pubitemid 46440627)
66. Ambasudhan R, Wang X, Jablonski MM, et al. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein. Genomics 2004;83:615-25. (Pubitemid 38340803)
67. Karan G, Yang Z, Zhang K. Expression of wild type and mutant ELOVL4 in cell culture: subcellular localization and cell viability. Mol Vis 2004;10:248-53. (Pubitemid 38628955)
68. Grayson C, Molday RS. Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4. J Biol Chem 2005;280:32521-30. (Pubitemid 41361866)
69. Vasireddy V, Vijayasarathy C, Huang J, et al. Stargardt-like macular dystrophy protein ELOVL4 exerts a dominant negative effect by recruiting wild-type protein into aggresomes. Mol Vis 2005;11:665-76. (Pubitemid 41410207)
70. Zhang K, Kaufman RJ. Signaling the unfolded protein response from the endoplasmic reticulum. J Biol Chem 2004;279:25935-8. (Pubitemid 38798732)
71. Leonard AE, Kelder B, Bobik EG, et al. Identification and expression of mammalian long-chain PUFA elongation enzymes. Lipids 2002;37:733-40.
72. Seddon JM, George S, Rosner B. Cigarette smoking, fish consumption, omega-3 fatty acid intake, and associations with age-related macular degeneration: the US twin study of age-related macular degeneration. Arch Ophthalmol 2006;124:995-1001. (Pubitemid 44036322)
73. Chong EW, Kreis AJ, Wong TY, et al. Dietary omega-3 fatty acid and fish intake in the primary prevention of age-related macular degeneration: a systematic review and meta-analysis. Arch Ophthalmol 2008;126:826-33.
74. Johnson EJ, Chung HY, Caldarella SM, et al. The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr 2008;87:1521-9.
75. Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 2006;1:420-39.
76. Bazan NG. Omega-3 fatty acids, pro-inflammatory signaling and neuroprotection. Curr Opin Clin Nutr Metab Care 2007;10:136-41.
77. Robinson BS, Johnson DW, Poulos A. Unique molecular species of phosphatidylcholine containing very-long-chain (C24-C38) polyenoic fatty acids in rat brain. Biochem J 1990;265:763-7.
78. Butovich IA, Uchiyama E, McCulley JP. Lipids of human meibum: mass-spectrometric analysis and structural elucidation. J Lipid Res 2007;48:2220-35. (Pubitemid 47529564)
79. Butovich IA. Cholesteryl esters as a depot for very long chain fatty acids in human meibum. J Lipid Res 2009;50:501-13.
80. Furland NE, Zanetti SR, Oresti GM, et al. Ceramides and sphingomyelins with high proportions of very long-chain polyunsaturated fatty acids in mammalian germ cells. J Biol Chem 2007;282:18141-50.
81. Sandhoff R, Geyer R, Jennemann R, et al. Novel class of glycosphingolipids involved in male fertility. J Biol Chem 2005;280:27310-18. (Pubitemid 41040772)
82. Rissmann R, Groenink HW, Weerheim AM, et al. New insights into ultrastructure, lipid composition and organization of vernix caseosa. J Invest Dermatol 2006;126:1823-33. (Pubitemid 44086517)
83. Karan G, Yang Z, Howes K, et al. Loss of ER retention and sequestration of the wild-type ELOVL4 by Stargardt disease dominant negative mutants. Mol Vis 2005;11:657-64. (Pubitemid 41410208)